| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 129 / 144 | 10th | Q4 |
| Clinical Biochemistry | 115 / 124 | 7th | Q4 |
| Molecular Medicine | 171 / 179 | 4th | Q4 |
| Physiology | 190 / 196 | 3rd | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Biochemistry in Health and Disease
Advances in Biochemistry in Health and Disease is Scopus-indexed (Q4, CiteScore 0.7). Published by Springer Nature.
Checked against the index lists dated .
ISSN 2512-2142Verify ISSN ↗2512-2150Verify ISSN ↗
Publisher: Springer Nature
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Advances in Biochemistry in Health and Disease indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2020–present (also 2013–2017, 2007–2008), best quartile Q4, CiteScore 0.7.
What quartile is Advances in Biochemistry in Health and Disease in Scopus?
Advances in Biochemistry in Health and Disease is Q4 in Biochemistry, Genetics and Molecular Biology (miscellaneous) (rank 129 of 144), Q4 in Clinical Biochemistry (rank 115 of 124) and Q4 in Molecular Medicine (rank 171 of 179), by CiteScore 2025. It is ranked in 4 subject areas in all.
What is the impact factor of Advances in Biochemistry in Health and Disease?
Advances in Biochemistry in Health and Disease is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.7, quartile Q4, 10th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Who publishes Advances in Biochemistry in Health and Disease and what is its ISSN?
Advances in Biochemistry in Health and Disease is published by Springer Nature. Its print ISSN is 2512-2142 and its online ISSN is 2512-2150.
Is Advances in Biochemistry in Health and Disease in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Advances in Biochemistry in Health and Disease open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Advances in Biochemistry in Health and Disease? — open metrics via OpenAlex
Advances in Biochemistry in Health and Disease has an h-index of 8 and a 2-year mean of 0.75 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #111 of 141 Scopus journals in Biochemistry, Genetics and Molecular Biology (miscellaneous).
Advances in Biochemistry in Health and Disease published 41 papers in 2025; its busiest recent year was 2024 with 147. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Advances in Biochemistry in Health and Disease? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.